LONDON MARKET CLOSE: FTSE 100 flat, despite buoyant banks, as US falls
21st Feb 2025 17:01
(Alliance News) - The FTSE 100 faded into the close on Friday, ending little changed, as US markets fell amid soft economic data. Read More
(Alliance News) - The FTSE 100 faded into the close on Friday, ending little changed, as US markets fell amid soft economic data. Read More
(Alliance News) - London's FTSE 100 held modest gains around midday Friday, with strong retail sales figures providing some impetus, although mixed borrowing data could provide another headache for Chancellor Rachel Reeves. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday. Read More
(Alliance News) - Stocks in Europe started the day mixed on Friday, with the FTSE 100 set for a weekly decline, in largely lifeless trade to kick off the final day of the week as eyes turn to PMI readings in Europe and beyond. Read More
(Alliance News) - Poolbeg Pharma PLC on Friday said it is "surprised and disappointed" by Hookipa Pharma Inc opting against making a bid for the company. Read More
(Alliance News) - London's FTSE 100 is set for a tepid open, continuing a rough week for the blue-chip benchmark, and following the lead of US stocks which fell overnight. Read More
(Alliance News) - Hookipa Pharma Inc on Thursday said it is not going ahead with a bid for Poolbeg Pharma PLC. Read More
Poolbeg Pharma PLC - London-based clinical stage biopharmaceutical firm - Updates on Gilead Sciences Inc's intentions regarding potential Hookipa Pharma Inc combination. Notes its intention to vote in line with the board of Hookipa in the instance of a formal offer and that it will participate in the proposed concurrent fundraise in an amount up to USD8.7 million. Says this is consistent with its existing contractual obligations. Hookipa intends to fundraise up to approximately USD30 million. Gilead currently owns a 19% stake in Hookipa. Poolbeg notes that all combination discussions have been non-binding in nature with no certainty present that a formal offer will be made. Read More
Poolbeg Pharma PLC - London-based clinical stage biopharmaceutical firm - Confirms that Gilead Sciences Inc, a significant shareholder in Hookipa Pharma Inc, intends to vote in line with the Hookipa board recommendation on the potential combination of Poolbeg and Hookipa, if a formal offer were to be made. Gilead currently owns a 19% stake in Hookipa, and also intends to participate in the proposed fundraise for up to USD30 million upon completion of the deal. Oppenheimer & Co Inc has been engaged by Hookipa in connection with the fundraise. Read More
(Alliance News) - London's FTSE 100 made an impressive start to the new year, shrugging aside drab manufacturing data, lifted by rising oil majors, gold miners and retailers. Read More
(Alliance News) - Stocks in London were mixed around midday on Thursday with rising commodity prices boosting gold miners and oil majors, helping to offset falls for banks and airlines. Read More
(Alliance News) - Poolbeg Pharma PLC on Thursday said it was holding talks over an all-share combination with US-listed biopharmaceutical company Hookipa Pharma Inc. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More
(Alliance News) - London's FTSE 100 is set to open the year in the green, with a series of manufacturing purchasing managers' index readings the first hurdle for equities in 2025. Read More
(Alliance News) - Poolbeg Pharma PLC on Wednesday announced its immunomodulator I patent has been granted in the US. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - Poolbeg Pharma PLC on Wednesday said that it has received a fully granted patent from the US Patent Office for its Immunomodulator II patent application. Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More